Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bossi

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
Frontiers in Surgery|June 24, 2022
The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study ProtocolGiancarlo Marra, Taimur T Shah, Daniele D'Agate, et al.
BJU International|January 26, 2019
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essayCharlien Berghen, Maarten Albersen, Pierre Blanchard, et al.
World Journal of Urology|August 31, 2013
Nomograms to predict late urinary toxicity after prostate cancer radiotherapyRomain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, et al.
Cancer Communications (London, England)|May 15, 2026
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex ConjugatesValentina Pagliara, Giulia Assoni, Giovanna Polcaro, et al.
Lancet (London, England)|November 23, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial designAlberto Bossi, Stéphanie Foulon, Xavier Maldonado, et al.
The Prostate|June 9, 2017
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network studyBerardino De Bari, Bradley Stish, Mark Wayne Ball, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2018
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug groupEmmanuel Meyer, David Pasquier, Guillemette Bernadou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysisNajlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2025
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trialGuilhem Roubaud, Marie Kostine, Raymond S McDermott, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
Frontiers in Surgery|June 24, 2022
The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study ProtocolGiancarlo Marra, Taimur T Shah, Daniele D'Agate, et al.
BJU International|January 26, 2019
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essayCharlien Berghen, Maarten Albersen, Pierre Blanchard, et al.
World Journal of Urology|August 31, 2013
Nomograms to predict late urinary toxicity after prostate cancer radiotherapyRomain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, et al.
Cancer Communications (London, England)|May 15, 2026
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex ConjugatesValentina Pagliara, Giulia Assoni, Giovanna Polcaro, et al.
Lancet (London, England)|November 23, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial designAlberto Bossi, Stéphanie Foulon, Xavier Maldonado, et al.
The Prostate|June 9, 2017
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network studyBerardino De Bari, Bradley Stish, Mark Wayne Ball, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2018
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug groupEmmanuel Meyer, David Pasquier, Guillemette Bernadou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysisNajlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2025
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trialGuilhem Roubaud, Marie Kostine, Raymond S McDermott, et al.
Pageof 15